Home / Inspections / 1313468

FDA Inspection 1313468 — Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. — FEI 1971534

The FDA completed an inspection of Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. on March 26, 2026 in Topeka, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 26, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Topeka, KS (United States)

Facility

Other inspections at this facility

  • 1090664 (NAI Wed May 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996509 (NAI Thu Dec 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903947 (NAI Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836157 (VAI Mon Jun 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 767479 (VAI Mon Jan 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources